Skip to main content

T1D and AI in Diabetic Retinopathy Screening

This webinar featured projects from our trainees from across the country with representation from Ontario, Manitoba, Alberta and Quebec. Topics and speakers include:

  • Person Impact Story: Debbie Sissmore 
  • Restructuring Type 1 Diabetes and Exercise Research in the Context of Patient Engagement
    • Presented by: Nika Klaprat
  • Narrative inquiry into understanding the type 1 diabetes lived experience and its motivations in seeking diabetes health services and education in Alberta
    • Presented by: Jamie Boisvenue
  • Artificial Intelligence for Diabetic Retinopathy Screening
    • Presented by: Gabriel Lepetit-Aimon & Clément Playout

Subscribe on YouTube

Tele-ophthalmology program in Canada with Diabetes Action Canada

Tele-ophthalmology program in Canada with Diabetes Action Canada

Diabetic retinopathy is a complication of diabetes and accounts for 80% of diabetic-related blindness. It is the leading cause of blindness for working age Canadians. Early detection of diabetic retinopathy by regular screening effectively avoids vision loss from diabetes as necessary treatments prevent irreversible retina damage.